Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products.

Press Release/Announcement

Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products.

November 23, 2005

U.S. Food and Drug Administration; FDA; CDER; Center for Drug Evaluation and Research; MedWatch.

This announcement reports on potential for falsely elevated glucose readings in patients taking parenteral maltose, parenteral galactose, or oral xylose and provides a list of products that may interfere with glucose monitoring.

Related Resources From the Same Author(s)

Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine.

February 22, 2006

Promethazine HCl (marketed as Phenergan) Information.

May 3, 2006

Medicines in My Home.

August 2, 2006

Postmarket Drug Safety Information for Patients and Providers.

November 19, 2008

Questions and Answers on FDA's Adverse Event Reporting System (FAERS).

September 17, 2008

Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry.

January 9, 2013

Bar Code Label Requirements for Blood and Blood Components.

April 26, 2006

Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry.

December 23, 2020

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

FDA Patient Safety News. A Video News Show for Health Professionals.

March 6, 2005

Interference between CT and Electronic Medical Devices.

July 30, 2008

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

March 3, 2010

FDA public health notification: unretrieved device fragments.

January 30, 2008

FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).

June 3, 2015

Shelhigh, Inc. implantable medical devices.

May 2, 2007

SmartTots.

April 13, 2011

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

Teaching Kids About Using Medicine Safely.

February 29, 2012

BeSafeRx: Know Your Online Pharmacy.

October 10, 2012

Lock it Up: Medicine Safety in Your Home.

November 30, 2011

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

OpenFDA.

June 11, 2014

Be an Active Member of Your Health Care Team.

May 21, 2014

FDA MedWatch and Patient Safety Tutorial.

December 10, 2008

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

September 29, 2010

MedWatch E-list.

March 6, 2005

Human Factors and Medical Devices.

March 27, 2005

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

March 22, 2006

Wear face masks with no metal during MRI exams.

December 16, 2020

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change.

January 9, 2005

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

June 7, 2006

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

April 8, 2009

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

January 25, 2017

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

October 7, 2009

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

Relenza (zanamivir) inhalation powder.

October 21, 2009

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

October 21, 2009

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

February 20, 2008

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

November 19, 2008

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

July 26, 2006

Safe Use Initiative.

November 18, 2009

6 Tips to Avoid Medication Mistakes.

July 18, 2007

Quick Tips for Buying Medicines Over the Internet.

March 6, 2005

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

Four Medication Safety Tips for Older Adults.

June 18, 2014

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

March 26, 2008

FDA 101: How to Use the Consumer Complaint System and MedWatch.

June 25, 2008

Reprocessing of Reusable Medical Devices.

January 11, 2012

Safety Information on Alaris SE Infusion Pumps.

November 15, 2006

MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

June 22, 2005

Drug Shortages.

April 27, 2011

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Examples of Medical Device Misconnections.

March 8, 2023

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

FDA/ISMP Safe Medication Management Fellowship Program.

February 8, 2023

Strategic Plan for Preventing and Mitigating Drug Shortages.

November 13, 2013

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

An Introduction to the Improved FDA Prescription Drug Labeling.

November 1, 2006

Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff.

October 3, 2022

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health.

June 6, 2018

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication

November 6, 2019

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

A Review of FDA’s Approach to Medical Product Shortages.

November 16, 2011

Related Resources

WebM&M Cases

Hospital-Acquired Diabetic Ketoacidosis.

February 1, 2023

Reducing potential errors associated with insulin administration: an integrative review.

December 14, 2022

Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review.

October 5, 2022

Administering High-Strength Insulin from a Pen Device in Hospital.

September 14, 2022

WebM&M Cases

Challenges of Diabetes Management and Medication Reconciliation

August 5, 2022

Adverse glycemic events and critical emergencies.

December 15, 2021

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Acting wisely in complex clinical situations: 'Mutual safety' for clinicians as well as patients.

October 13, 2021

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Outpatient insulin-related adverse events due to mix-up errors: findings from two national surveillance systems, United States, 2012-2017.

March 24, 2021

Effect of a multifaceted clinical pharmacist intervention on medication safety after hospitalization in persons prescribed high-risk medications: a randomized clinical trial.

March 17, 2021

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Patient errors in use of injectable antidiabetic medications: a need for improved clinic-based education.

November 4, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Is one-pen, one-patient achievable in the hospital? A quality improvement project to reduce risks of inadvertent insulin pen sharing at a large academic medical center.

January 29, 2020

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

WebM&M Cases

Duplicate Insulin Order

March 1, 2019

Evaluation of harm associated with high dose-range clinical decision support overrides in the intensive care unit.

January 23, 2019

Insulin pumps have most reported problems in FDA database.

December 5, 2018

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Development and implementation of a subcutaneous insulin pen label bar code scanning protocol to prevent wrong-patient insulin pen errors.

November 21, 2018

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Making surgical wards safer for patients with diabetes: reducing hypoglycaemia and insulin errors.

August 8, 2018

Randomized controlled evaluation of an insulin pen storage policy.

February 14, 2018

Severe hyperglycemia in patients incorrectly using insulin pens at home.

October 25, 2017

Hardwiring safety into the computer system: one hospital's actions to provide technology support for U-500 insulin.

May 18, 2016

See More About The Topic

Health Care Providers

Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

PSNet Log in

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site